Phase 2 early afterdepolarization as a trigger of polymorphic ventricular tachycardia in acquired long-QT syndrome : direct evidence from intracellular recordings in the intact left ventricular wall

Circulation. 2001 Jun 12;103(23):2851-6. doi: 10.1161/01.cir.103.23.2851.

Abstract

Background: This study examined the role of phase 2 early afterdepolarization (EAD) in producing a trigger to initiate torsade de pointes (TdP) with QT prolongation induced by dl-sotalol and azimilide. The contribution of transmural dispersion of repolarization (TDR) to transmural propagation of EAD and the maintenance of TdP was also evaluated.

Methods and results: Transmembrane action potentials from epicardium, midmyocardium, and endocardium were recorded simultaneously, together with a transmural ECG, in arterially perfused canine and rabbit left ventricular preparations. dl-Sotalol preferentially prolonged action potential duration (APD) in M cells dose-dependently (1 to 100 micromol/L), leading to QT prolongation and an increase in TDR. Azimilide, however, significantly prolonged APD and QT interval at concentrations from 0.1 to 10 micromol/L but shortened them at 30 micromol/L. Unlike dl-sotalol, azimilide (>3 micromol/L) increased epicardial APD markedly, causing a diminished TDR. Although both dl-sotalol and azimilide rarely induced EADs in canine left ventricles, they produced frequent EADs in rabbits, in which more pronounced QT prolongation was seen. An increase in TDR by dl-sotalol facilitated transmural propagation of EADs that initiated multiple episodes of spontaneous TdP in 3 of 6 rabbit left ventricles. Of note, although azimilide (3 to 10 micromol/L) increased APD more than dl-sotalol, its EADs often failed to propagate transmurally, probably because of a diminished TDR.

Conclusions: This study provides the first direct evidence from intracellular action potential recordings that phase 2 EAD can be generated from intact ventricular wall and produce a trigger to initiate the onset of TdP under QT prolongation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Action Potentials / drug effects
  • Animals
  • Anti-Arrhythmia Agents / pharmacology
  • Dogs
  • Dose-Response Relationship, Drug
  • Electrocardiography / drug effects
  • Electrophysiologic Techniques, Cardiac
  • Heart Conduction System / drug effects
  • Heart Conduction System / physiopathology*
  • Heart Ventricles / drug effects
  • Heart Ventricles / physiopathology
  • Hydantoins
  • Imidazoles / pharmacology
  • Imidazolidines*
  • In Vitro Techniques
  • Long QT Syndrome / complications
  • Long QT Syndrome / physiopathology*
  • Myocardial Contraction / drug effects
  • Piperazines / pharmacology
  • Rabbits
  • Sotalol / pharmacology
  • Species Specificity
  • Systole / drug effects
  • Tachycardia, Ventricular / complications
  • Tachycardia, Ventricular / physiopathology*
  • Ventricular Dysfunction, Left / etiology
  • Ventricular Dysfunction, Left / physiopathology*

Substances

  • Anti-Arrhythmia Agents
  • Hydantoins
  • Imidazoles
  • Imidazolidines
  • Piperazines
  • azimilide
  • Sotalol